Similar to AML, GPX4 expression was elevated in MM plasma cells compared to healthy counterparts, suggesting potential utilization of this antioxidant pathway to counteract elevated ROS levels [35]. This evidence concerns the gene GPX4 and acute myeloid leukemia.